Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
AST SpaceMobile A | ASTS | Nov 22, 2024 | 24.10 | -0.17 |
Astec Industries | ASTE | Nov 22, 2024 | 38.25 | +3.35 |
Astera Labs | ALAB | Nov 22, 2024 | 102.28 | -1.77 |
Astrana Health | ASTH | Nov 22, 2024 | 42.11 | 0.00 |
AstraZeneca ADR | AZN | Nov 22, 2024 | 65.63 | +2.13 |
Astria Therapeutics | ATXS | Nov 22, 2024 | 9.65 | +3.32 |
Astronics | ATRO | Nov 22, 2024 | 17.22 | +0.47 |
AstroNova | ALOT | Nov 22, 2024 | 14.77 | -1.53 |
Astrotech | ASTC | Nov 22, 2024 | 7.70 | +1.18 |
Asure Software | ASUR | Nov 22, 2024 | 9.65 | +1.37 |
AT&T | T | Nov 22, 2024 | 23.18 | +0.87 |
AT&T A Pref | T-A | Nov 22, 2024 | 21.53 | +0.42 |
AT&T C Pref | T-C | Nov 22, 2024 | 20.32 | -0.29 |
ATA Creativity Global ADR | AACG | Nov 22, 2024 | 1.02 | +0.99 |
Atai Life Sciences BV | ATAI | Nov 22, 2024 | 1.61 | +5.92 |
Atara Biotherapeutics | ATRA | Nov 22, 2024 | 11.47 | +8.11 |
Atea Pharmaceuticals | AVIR | Nov 22, 2024 | 3.37 | +3.69 |
Aterian | ATER | Nov 22, 2024 | 2.58 | +7.50 |
Athena Technology Acquisition II | ATEK | Nov 22, 2024 | 11.75 | 0.00 |
Athene A Pref | ATH-A | Nov 22, 2024 | 25.22 | +0.08 |
Athene B Pref | ATH-B | Nov 22, 2024 | 22.02 | +1.06 |
Athene C Pref | ATH-C | Nov 22, 2024 | 25.27 | -0.32 |
Athene D Pref | ATH-D | Nov 22, 2024 | 19.23 | +0.42 |
Athene Holding | ATH-E | Nov 22, 2024 | 26.98 | +0.26 |
Athira Pharma | ATHA | Nov 22, 2024 | 0.64 | -2.59 |
Ati Physical Therapy A | ATIP | Nov 22, 2024 | 1.82 | +20.53 |
ATIF Holdings | ATIF | Nov 22, 2024 | 0.64 | -2.41 |
Atkore | ATKR | Nov 22, 2024 | 89.69 | +5.34 |
Atlanta Braves A | BATRA | Nov 22, 2024 | 41.97 | +1.45 |
Atlanta Braves C | BATRK | Nov 22, 2024 | 40.19 | +1.46 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.